Tag: elafibranor
Primary Biliary Cholangitis Treatment in 2025: What Works, What Changed, and What to Expect
- Dec, 4 2025
In 2025, PBC treatment has shifted dramatically after obeticholic acid was withdrawn. UDCA remains first-line, but seladelpar and elafibranor now offer effective second-line options with better safety and symptom relief.
- Read More